curacle co.,ltd. (KOSDAQ:365270)
South Korea · Delayed Price · Currency is KRW 17,460
-440 (-2.46%)
At close: Feb 26, 2026
curacle co.,ltd. Revenue
curacle co.,ltd. had revenue of 7.10M KRW in the quarter ending September 30, 2025. This brings the company's revenue in the last twelve months to 1.14B, down -35.69% year-over-year. In the year 2024, curacle co.,ltd. had annual revenue of 1.63B, down -84.14%.
Revenue (ttm)
1.14B
Revenue Growth
-35.69%
P/S Ratio
347.85
Revenue / Employee
n/a
Employees
n/a
Market Cap
396.47B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 1.63B | -8.66B | -84.14% |
| Dec 31, 2023 | 10.29B | 6.71B | 187.32% |
| Dec 31, 2022 | 3.58B | -2.67B | -42.72% |
| Dec 31, 2021 | 6.25B | - | - |
| Dec 31, 2020 | - | - | - |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| HansBiomed | 100.17B |
| ISU Abxis | 66.39B |
| NIBEC | 32.96B |
| Genome & Company | 25.95B |
| Prestige Biologics | 19.24B |
| S.Biomedics | 16.96B |
| QuadMedicine | 13.11B |
| Kangstem Biotech | 12.77B |